Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?
- PMID: 1471702
- DOI: 10.1016/0002-9378(92)91779-a
Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?
Abstract
Objective: Our purpose was to determine the prevalence of adrenal hyperandrogenism and insulin resistance in patients with hyperandrogenic chronic anovulation, also called polycystic ovary syndrome, living in the United States, Italy, and Japan.
Study design: Seventy-five women with polycystic ovary syndrome, 25 each from the United States, Italy, and Japan, and 10 ovulatory controls were studied. Hirsutism, obesity, and the presence of cystic ovaries were assessed, as were blood levels for estrogen, luteinizing hormone, testosterone, adrenal androgens, and insulin. All patients received an insulin tolerance test to assess insulin resistance.
Results: Women from Japan were less obese (p < 0.05) and did not have hirsutism, although the percentage of cystic ovaries (68% to 80%) was comparable. Serum luteinizing hormone, testosterone, and estradiol were similar, but levels of 3 alpha-androstanediol glucuronide, which was elevated in women from the United States and Italy, was normal in women from Japan. The adrenal androgens, dehydroepiandrosterone sulfate and 11 beta-hydroxyandrostenedione were elevated in 48% to 64% of the patients and by a similar percentage in the three groups. Fasting insulin was elevated in all groups, but was significantly higher in women from the United States and Italy compared with women from Japan (p < 0.05). However, insulin resistance as assessed by dissociation constant of insulin tolerance test values was significantly elevated but similar in the three groups and occurred in 68% to 76% of patients.
Conclusion: In polycystic ovary syndrome, although obesity and hirsutism vary according to dietary, genetic, and environmental factors, the prevalence of adrenal androgen excess and insulin resistance appear to be fairly uniform. These results suggest that these factors may be involved in the pathophysiologic features of the disorder.
Similar articles
-
Polycystic ovary syndrome.Endocrinol Metab Clin North Am. 1997 Dec;26(4):893-912. doi: 10.1016/s0889-8529(05)70286-3. Endocrinol Metab Clin North Am. 1997. PMID: 9429864 Review.
-
The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome.J Clin Endocrinol Metab. 1993 May;76(5):1295-300. doi: 10.1210/jcem.76.5.8388405. J Clin Endocrinol Metab. 1993. PMID: 8388405
-
Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.J Clin Endocrinol Metab. 1987 Sep;65(3):499-507. doi: 10.1210/jcem-65-3-499. J Clin Endocrinol Metab. 1987. PMID: 3305551
-
Polycystic ovaries in Hirsute women with normal menses.Am J Med. 2001 Dec 1;111(8):602-6. doi: 10.1016/s0002-9343(01)00979-2. Am J Med. 2001. PMID: 11755502
-
Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus.Am J Med. 1995 Jan 16;98(1A):33S-39S. doi: 10.1016/s0002-9343(99)80057-6. Am J Med. 1995. PMID: 7825639 Review.
Cited by
-
The impact of hyperandrogenism on the outcomes of ovulation induction using gonadotropin and intrauterine insemination in women with polycystic ovary syndrome.Clin Exp Reprod Med. 2022 Jun;49(2):127-134. doi: 10.5653/cerm.2022.05204. Epub 2022 May 27. Clin Exp Reprod Med. 2022. PMID: 35698775 Free PMC article.
-
Preliminary Findings of Platelet-Rich Plasma-Induced Ameliorative Effect on Polycystic Ovarian Syndrome.Cell J. 2019 Oct;21(3):243-252. doi: 10.22074/cellj.2019.5952. Epub 2019 Jun 15. Cell J. 2019. PMID: 31210429 Free PMC article.
-
Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity.Int J Environ Res Public Health. 2018 Nov 20;15(11):2589. doi: 10.3390/ijerph15112589. Int J Environ Res Public Health. 2018. PMID: 30463276 Free PMC article. Review.
-
Polycystic Ovary Syndrome: A Disorder of Reproductive Age, Its Pathogenesis, and a Discussion on the Emerging Role of Herbal Remedies.Front Pharmacol. 2022 Jul 18;13:874914. doi: 10.3389/fphar.2022.874914. eCollection 2022. Front Pharmacol. 2022. PMID: 35924049 Free PMC article. Review.
-
Heterogeneity of Endocrinologic and Metabolic Parameters in Reproductive Age Polycystic Ovary Syndrome (PCOS) Women Concerning the Severity of Hyperandrogenemia-A New Insight on Syndrome Pathogenesis.Int J Environ Res Public Health. 2020 Dec 11;17(24):9291. doi: 10.3390/ijerph17249291. Int J Environ Res Public Health. 2020. PMID: 33322590 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical